SANUWAVE Health, Inc. - Common Stock (SNWV)
Frequently Asked Questions About SANUWAVE Health, Inc. - Common Stock (SNWV)
Does SANUWAVE have any partnerships or collaborations?
Yes, SANUWAVE has established partnerships and collaborations with various healthcare organizations and research institutions. These partnerships are aimed at advancing clinical research, expanding product applications, and enhancing market access for its innovative therapies.
How does SANUWAVE's Acoustic Cellular Technology work?
SANUWAVE's Acoustic Cellular Technology operates by applying acoustic shockwaves to targeted areas of the body. These shockwaves help stimulate cellular activity, increasing blood flow and promoting the regeneration of tissues to expedite healing processes and improve patient outcomes.
How is SANUWAVE funded?
SANUWAVE Health, Inc. has historically funded its operations and product development through a combination of public offerings, private investments, and partnerships. As a publicly traded company, it continues to seek funding avenues to support its technological advancements and expand its market presence.
How many employees does SANUWAVE have?
The workforce at SANUWAVE Health, Inc. is relatively small and consists of a dedicated team specializing in research and development, marketing, and operational management. The company aims to attract talent that is innovative and aligned with its mission to advance healthcare technologies.
Is SANUWAVE Health publicly traded?
Yes, SANUWAVE Health, Inc. is publicly traded on the NASDAQ stock exchange under the ticker symbol SNWV. As a publicly traded company, its shares can be bought and sold by investors in the stock market.
What are the potential applications of SANUWAVE's technology?
The technology developed by SANUWAVE has several potential applications across multiple fields, including chronic wound care, orthopedic treatments, and aesthetic medicine. The ability to promote healing and tissue regeneration opens up new possibilities for treating various conditions effectively.
What does SANUWAVE Health, Inc. do?
SANUWAVE Health, Inc. is a medical technology company that focuses on regenerative medicine through the development of novel non-invasive therapies. The company's primary concentration is on the use of its patented Acoustic Cellular Technology to promote healing and tissue regeneration in a variety of medical applications, including wound care, orthopedic surgery, and aesthetic procedures.
What does SANUWAVE's future outlook look like?
The future outlook for SANUWAVE Health appears promising, as the demand for non-invasive medical solutions continues to rise. The company is focused on expanding its product portfolio, clinical applications, and market reach, positioning itself as a leader in regenerative medicine and innovative wound care solutions.
What industries does SANUWAVE Health operate in?
SANUWAVE Health operates primarily in the healthcare and medical device industries. Its focus on regenerative medicine and innovative technology positions it within the broader landscape of advanced medical therapies and wound care solutions.
What is SANUWAVE's approach to research and development?
SANUWAVE's approach to research and development involves a strong emphasis on innovation and scientific validation. The company invests in research initiatives to enhance its technology, improve its product offerings, and explore new applications to meet the evolving needs of patients and healthcare providers.
What is SANUWAVE's main product?
SANUWAVE's main product is the dermaPACE® device, which utilizes acoustic shockwave technology to enhance healing in chronic wounds such as diabetic foot ulcers and venous leg ulcers. The device is designed to accelerate tissue regeneration and improve overall patient outcomes.
What is SANUWAVE's target market?
SANUWAVE's target market encompasses healthcare providers, such as hospitals and clinics, focusing on chronic wound care, orthopedic therapy, and aesthetic medicine. The growing demand for effective and non-invasive treatment options in these sectors positions SANUWAVE's offerings well within the market.
What is the clinical evidence supporting SANUWAVE's products?
SANUWAVE has conducted multiple clinical studies that demonstrate the effectiveness of its products, particularly the dermaPACE® device. The results have shown promising outcomes in terms of improved healing rates for chronic wounds and reduced recovery times, underpinning the clinical credibility of its technology.
What is the company's vision and mission?
SANUWAVE Health, Inc.'s vision is to become a leader in regenerative medicine and medical technology by offering innovative, effective, and safe treatment options that significantly improve patient outcomes. Its mission is to revolutionize healing through non-invasive technologies, making advanced medical care accessible to patients worldwide.
What is the significance of SANUWAVE's technology in wound care?
SANUWAVE's technology is significant in wound care because it addresses the growing challenge of chronic wounds, which can lead to serious complications, including amputations. By utilizing non-invasive acoustic shockwave therapy, SANUWAVE provides a promising alternative that has the potential to significantly enhance healing rates and improve quality of life for patients.
What regulatory approvals has SANUWAVE received?
SANUWAVE's products, including the dermaPACE® device, have received regulatory approval from various bodies, including the U.S. Food and Drug Administration (FDA) and CE Mark certification in Europe. These approvals enable the company to market its products in specific regions, validating their safety and efficacy.
When was SANUWAVE Health, Inc. founded?
SANUWAVE Health, Inc. was founded in 2007. The company was established with the objective of advancing non-invasive treatment options that can help patients recover better and faster, reducing the need for invasive surgical procedures.
Where is SANUWAVE Health, Inc. headquartered?
The headquarters of SANUWAVE Health, Inc. is located in Suwanee, Georgia, USA. This location allows the company to benefit from a skilled workforce, proximity to major healthcare markets, and easy access to research and development resources.
Who are SANUWAVE's competitors?
SANUWAVE competes with a variety of companies in the regenerative medicine and medical device sectors. Key competitors may include both established medical technology firms and newer startups that specialize in wound healing and orthopedic solutions, particularly those employing novel non-invasive therapies.
What is the current price of SANUWAVE Health, Inc. - Common Stock?
The current price of SANUWAVE Health, Inc. - Common Stock is 30.10
When was SANUWAVE Health, Inc. - Common Stock last traded?
The last trade of SANUWAVE Health, Inc. - Common Stock was at 4:00 pm EDT on May 9th, 2025
What is the market capitalization of SANUWAVE Health, Inc. - Common Stock?
The market capitalization of SANUWAVE Health, Inc. - Common Stock is 16.52B
How many shares of SANUWAVE Health, Inc. - Common Stock are outstanding?
SANUWAVE Health, Inc. - Common Stock has 548.74M shares outstanding.